TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06433232 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05691153 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05824221 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05824221 — Safety Biomarker (SAF): BDNF
Study NCT05395143 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05544123 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05544123 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05031858 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06491927 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05590871 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04995328 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04544007 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06011863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06043635 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT06043635 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT04733456 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05465863 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05649618 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04114890 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06245928 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04857138 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04857138 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06619704 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06619704 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06619704 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06619704 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05008380 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04831164 — Predictive Biomarker (PRD): BCL2A1 mRNA
Genes: BCL2A1; BCL2L5; BFL1; GRS; HBPA1
Study NCT05879874 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06698029 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT06066749 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05871463 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05726058 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04999280 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05869136 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05576831 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05576831 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05392959 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05543720 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06183138 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study NCT06555640 — Predictive Biomarker (PRD): GCGR mRNA
Genes: GCGR
Study NCT06555640 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05562011 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05718180 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study NCT05426395 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06339424 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06339424 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06339424 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06134635 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06581640 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04840992 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00000687 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05626569 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05397444 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study NCT06624488 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT06624488 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06624488 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study NCT06624488 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06627972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05854563 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study NCT05854563 — Predictive Biomarker (PRD): SFTPC mRNA
Genes: SFTPC; SFTP2
Study NCT05190627 — Predictive Biomarker (PRD): VEGFD mRNA
Genes: VEGFD; FIGF
Study NCT05181150 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05663255 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04955990 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05974085 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT05540145 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05197816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04058210 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05052580 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05856760 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06356077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06050239 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05281354 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05281354 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05474690 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05532098 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06551896 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT04846686 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05245500 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT05729048 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04125862 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study NCT04435782 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06249867 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06513052 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06520904 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04888767 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04807595 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04807595 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05453487 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06049134 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05270824 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT00006152 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05920395 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT05920395 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT06459362 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05871437 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05539794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05539794 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06560034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06348888 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06348888 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06348888 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05113589 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04863131 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04646603 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06089395 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06161428 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT06083623 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06083623 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT05962164 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05623592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04864405 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05646316 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT05081193 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06515899 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT06277674 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01406535 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04889573 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05029427 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05717790 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05717790 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05571410 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06383130 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06042296 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT06042296 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06174558 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04170335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04170335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06518980 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05414721 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT04752527 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02963350 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT06413615 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05982925 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05128058 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study NCT05385835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05881928 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT06039891 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06039891 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06463262 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06174181 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06442852 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): miR-124
Study NCT06442852 — Pharmacodynamic Biomarker (PDY): miR-132
Genes: MIR132
Study NCT06214832 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05200442 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05686993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05624424 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05330780 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00053339 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05822726 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06283888 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05699538 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05589636 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06282549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05464784 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00002253 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT05909436 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT06180395 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06492369 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT05723796 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT04692337 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05517629 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05816655 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05816655 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05816655 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06650150 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06650150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT04573140 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06419946 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05772559 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06207253 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04758455 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05742087 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04971512 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05092464 — Safety Biomarker (SAF): Th2 cell
Study NCT04805840 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05569109 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04815668 — Predictive Biomarker (PRD): ST7 mRNA
Genes: ST7; FAM4A1; HELG; RAY1
Study NCT04815668 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05626348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05765877 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05765877 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05553405 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05583409 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05583409 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06027476 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06027476 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT06027476 — Safety Biomarker (SAF): Derived neutrophil to lymphocyte
Study NCT06339437 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04789330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01102023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05783934 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05783934 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05783934 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT04842019 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06394661 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06394661 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06394661 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06394661 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06394661 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06426771 — Predictive Biomarker (PRD): NKRF mRNA
Genes: NKRF; ITBA4; NRF
Study NCT06426771 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04070508 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT04476277 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04476277 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT06613490 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05802433 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT05802433 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05802433 — Predictive Biomarker (PRD): CYP2R1 mRNA
Genes: CYP2R1
Study NCT04965831 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05033145 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06632262 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT06632262 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT05203458 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05838716 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06273488 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04702464 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04702464 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04912609 — Predictive Biomarker (PRD): SPG11 mRNA
Genes: SPG11; KIAA1840
Study NCT05630469 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04786990 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT04576936 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT05342896 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06461156 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06461156 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06331650 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT05452213 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05452213 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06426407 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05103644 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06357741 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT06357741 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT06462495 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05408650 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05650073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05764317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04789733 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05295524 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05295524 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05141474 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06581081 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04534985 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT04534985 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT05198505 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05303441 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05317806 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT06088095 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05575557 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05705141 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06335186 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06335186 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04995354 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05174754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05024487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04284254 — Predictive Biomarker (PRD): IDUA mRNA
Genes: IDUA
Study NCT06268210 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04956289 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00292760 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05727579 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05727579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05341492 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05341492 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT05638230 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT06679257 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06677749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06677749 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT05869162 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05518331 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT06599619 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05036005 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05036005 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05036005 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05501158 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05261191 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06103760 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06504511 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT05219734 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05462717 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2